Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001370368-25-000007
Filing Date
2025-01-31
Accepted
2025-01-31 07:14:14
Documents
5
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 6-K a250131-6k.htm 6-K 15742
2 99.1 FINANCIAL REPORT Q4 2024 a250131-99_1.htm EX-99 299442
3 99.2 CONDENSED FINANCIAL REPORT a250131-99_2.htm EX-99 1619629
4 IMAGE logorm.jpg GRAPHIC 29788
5 IMAGE coverifr.jpg GRAPHIC 119121
  Complete submission text file 0001370368-25-000007.txt   2129747
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filer) CIK: 0001114448 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-15024 | Film No.: 25575911
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)